Advertisement

Topics

GSK to take control of Consumer Healthcare in £9.2bn buyout

03:56 EDT 27 Mar 2018 | Pharmafile

GSK has announced that it plans to purchase Novartis’ 36.5% stake in the joint Consumer Healthcare Business for a sum of £9.2 billion.

The decision comes days after GSK decided that it wouldn’t pursue a deal for Pfizer’s Consumer Healthcare unit.

read more

Original Article: GSK to take control of Consumer Healthcare in £9.2bn buyout

NEXT ARTICLE

More From BioPortfolio on "GSK to take control of Consumer Healthcare in £9.2bn buyout"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...